Let's put this together.... Suspect phase II data, no insurance coverage, BDH nightmare, 35% growth rate requirements, < 40% realistic response rate = a recipe for success. I think not. I'm sorry the corporates over promised investors on a non standard of care milkshake. But that's not my fault and it's not my sales ability 'JA' it's your rediculous expectations with a lack of understanding of your marketplace. Sure they can sell it in FLA, there are a bunch of rich retired patients not wanting to get old before there time but for the average marketplace I work damn hard to get my docs to write.
Heed this warning, 108 reps to 73 in less than a year. A few were fired but tops reps left, they cut their losses and moved forward before the hammer is dropped. Not to mention they aren't backfilling territories.